{"id":2454,"date":"2025-08-28T10:59:47","date_gmt":"2025-08-28T08:59:47","guid":{"rendered":"https:\/\/www.lamaisonpartners.fr\/?p=2454"},"modified":"2025-08-28T11:26:12","modified_gmt":"2025-08-28T09:26:12","slug":"exit-of-organox-within-nextgens-portfolio","status":"publish","type":"post","link":"https:\/\/www.lamaisonpartners.fr\/en\/exit-of-organox-within-nextgens-portfolio\/","title":{"rendered":"Exit of OrganOx within NextGen&#8217;s portfolio"},"content":{"rendered":"<p>\ud83d\ude80 Big news for La Maison NextGen !<\/p>\n<p>We are delighted to announce a new exit within the portfolio of our fund La Maison NextGen.<\/p>\n<p>Organox, a global pioneer in organ preservation and transportation, is entering a new growth phase through its acquisition by Terumo, a publicly listed Japanese leader and international medtech player.<\/p>\n<p>\ud83d\udc4f Congratulations to the <a class=\"lAZDHtSLDNLtCbloPenngRMakCrATOY \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/organox\/\" target=\"_self\" data-test-app-aware-link=\"\" rel=\"noopener\">OrganOx<\/a> team for their vision and commitment, and to our partner <a class=\"lAZDHtSLDNLtCbloPenngRMakCrATOY \" tabindex=\"0\" href=\"https:\/\/www.linkedin.com\/company\/lauxera-capital-partners\/\" target=\"_self\" data-test-app-aware-link=\"\" rel=\"noopener\">LAUXERA CAPITAL PARTNERS<\/a> for their valuable support.<\/p>\n<p>Beyond financial success, this transaction perfectly reflects the mission of La Maison Partners :<br \/>\n\u2728 Supporting high-potential technology champions,<br \/>\n\u2728 Building a dynamic and resilient portfolio,<br \/>\n\u2728 Creating long-term value for our investors,<br \/>\n\u2728 Identifying and co-investing alongside the best teams.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ud83d\ude80 Big news for La Maison NextGen ! We are delighted to announce a new exit within the portfolio of our fund La Maison NextGen. Organox, a global pioneer in organ preservation and transportation, is entering a new growth phase through its acquisition by Terumo, a publicly listed Japanese leader and international medtech player. \ud83d\udc4f [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":1958,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[75],"tags":[],"class_list":["post-2454","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-2025-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/posts\/2454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/comments?post=2454"}],"version-history":[{"count":2,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/posts\/2454\/revisions"}],"predecessor-version":[{"id":2460,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/posts\/2454\/revisions\/2460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/media\/1958"}],"wp:attachment":[{"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/media?parent=2454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/categories?post=2454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lamaisonpartners.fr\/en\/wp-json\/wp\/v2\/tags?post=2454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}